Abstract
In literature we see clear evidence of Angiotensin Converting Enzyme inhibitors (ACEI’s) causing visceral angioedema, but further evidence is required to establish the causality for Angiotensin Receptor Blockers (ARB’s). With the widespread usage of these anti-hypertensives and the potential serious adverse effect in the form of angioedema; clinicians should consider medication induced as part of their differentials.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
